Your browser doesn't support javascript.
loading
Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the Fmr1-KO Mouse Model of Fragile X Syndrome.
Premoli, Marika; Fyke, William; Bellocchio, Luigi; Lemaire, Valerie; Wolley-Roberts, Marie; Bontempi, Bruno; Pietropaolo, Susanna.
Afiliação
  • Premoli M; CNRS, EPHE, INCIA, UMR 5287, Univ. Bordeaux, 33000 Bordeaux, France.
  • Fyke W; Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
  • Bellocchio L; CNRS, EPHE, INCIA, UMR 5287, Univ. Bordeaux, 33000 Bordeaux, France.
  • Lemaire V; Graduate Program in Neural and Behavioral Science, SUNY Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USA.
  • Wolley-Roberts M; INSERM, U1215 NeuroCentre Magendie, Group Endocannabinoids and Neuroadaptation, University of Bordeaux, 33077 Bordeaux, France.
  • Bontempi B; CNRS, EPHE, INCIA, UMR 5287, Univ. Bordeaux, 33000 Bordeaux, France.
  • Pietropaolo S; Jazz Pharmaceuticals, Inc., Cambridge OX4 2RW, UK.
Cells ; 12(15)2023 07 25.
Article em En | MEDLINE | ID: mdl-37566006
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do Cromossomo X Frágil Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do Cromossomo X Frágil Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article